Skip to main content
Top
Published in: Breast Cancer 1/2017

01-01-2017 | Original Article

The functional capacity and quality of life of women with advanced breast cancer

Authors: K. Kokkonen, T. Saarto, T. Mäkinen, L. Pohjola, H. Kautio, S. Järvenpää, K. Puustjärvi-Sunabacka

Published in: Breast Cancer | Issue 1/2017

Login to get access

Abstract

Background

The rehabilitation needs of patients with metastatic breast cancer (MBC) are poorly studied. The primary aim of the study was to evaluate the functional capacity of women with MBC and quality of life (QoL).

Methods

The present study is an open, non-randomized, prospective cross-sectional observation study. The functional capacity of 128 MBC patients with ongoing cancer treatments, were studied in Helsinki University Hospital (HUS): Peak expiratory flow (PEF), dynamic and static balance, 6 minute walking distance (6MWD), 10 meter walking, sit-to-stand test, repeated squat, grip strength, shoulder movement, pain, and QoL by Beck’s depression scale (BDI), health assessment questionnaire (HAQ), RAND SF-36 and EORTC QLQ-30 items.

Results

The walking capacity was compromised in half and the strength of the lower extremities in one-third of the patients. PEF was below the normal reference in 55 %, static balance in 62 % and dynamic balance in 73 % (≤60 year olds) and 81 % (≥61 year olds). The grip power was lowered in 44/30 % of the patients (right/left) and the shoulder movement was restricted in 30 %. Some disability in physical functioning experienced 55 % (HAQ) and 37 % felt depressive (BDI). The QoL (RAND SF-36) was poor especially in the field of physical, role and social functioning and bodily pain (<0.001). Pain, depression, and a poor 6MWD results independently determined the physical component of QoL (p < 0.001).

Conclusions

The functional capacity of patients with MBC was significantly lowered. This, in association with distressing symptoms like pain and depression causes a vicious circle further leading to functional disabilities and impaired QoL.
Literature
1.
go back to reference Chia SK, Speers CH, D’yachkova Y, Kang A, Malfair-Taylor S, Barnett J, et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer. 2007;110:973–9.CrossRefPubMed Chia SK, Speers CH, D’yachkova Y, Kang A, Malfair-Taylor S, Barnett J, et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer. 2007;110:973–9.CrossRefPubMed
2.
go back to reference Lin NU, Burstein HJ. EMBRACE, eribulin, and new realities of advanced breast cancer. Lancet. 2011;377:878–80.CrossRefPubMed Lin NU, Burstein HJ. EMBRACE, eribulin, and new realities of advanced breast cancer. Lancet. 2011;377:878–80.CrossRefPubMed
3.
go back to reference Cheville AL, Troxel AB, Basford JR, Kornblith AB. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol. 2008;26:2621–9.CrossRefPubMedPubMedCentral Cheville AL, Troxel AB, Basford JR, Kornblith AB. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol. 2008;26:2621–9.CrossRefPubMedPubMedCentral
4.
go back to reference Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol. 2004;22:3302–8.CrossRefPubMed Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol. 2004;22:3302–8.CrossRefPubMed
5.
go back to reference Fialka-Moser V, Crevenna R, Korpan M, Quittan M. Cancer rehabilitation: particularly with aspects on physical impairments. J Rehabil Med. 2003;35:153–62.CrossRefPubMed Fialka-Moser V, Crevenna R, Korpan M, Quittan M. Cancer rehabilitation: particularly with aspects on physical impairments. J Rehabil Med. 2003;35:153–62.CrossRefPubMed
6.
go back to reference Fulton C. Patients with metastatic breast cancer: their physical and psychological rehabilitation needs. Int J Rehabil Res. 1999;22:291–301.CrossRefPubMed Fulton C. Patients with metastatic breast cancer: their physical and psychological rehabilitation needs. Int J Rehabil Res. 1999;22:291–301.CrossRefPubMed
7.
go back to reference Stricker CT, Drake D, Hoyer KA, Mock V. Evidence-based practice for fatigue management in adults with cancer: exercise as an intervention. Oncol Nurs Forum. 2004;31:963–76.CrossRefPubMed Stricker CT, Drake D, Hoyer KA, Mock V. Evidence-based practice for fatigue management in adults with cancer: exercise as an intervention. Oncol Nurs Forum. 2004;31:963–76.CrossRefPubMed
8.
go back to reference Ferrer RA, Huedo-Medina TB, Johnson BT, Ryan S, Pescatello LS. Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med. 2011;41:32–47.CrossRefPubMedPubMedCentral Ferrer RA, Huedo-Medina TB, Johnson BT, Ryan S, Pescatello LS. Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med. 2011;41:32–47.CrossRefPubMedPubMedCentral
9.
go back to reference Cheville AL, Kornblith AB, Basford JR. An examination of the causes for the underutilization of rehabilitation services among people with advanced cancer. Am J Phys Med Rehabil. 2011;90:S27–37.CrossRefPubMed Cheville AL, Kornblith AB, Basford JR. An examination of the causes for the underutilization of rehabilitation services among people with advanced cancer. Am J Phys Med Rehabil. 2011;90:S27–37.CrossRefPubMed
10.
go back to reference Adamowicz K, Jassem J, Katz A, Saad ED. Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trials. Cancer Treat Rev. 2012;38:554–8.CrossRefPubMed Adamowicz K, Jassem J, Katz A, Saad ED. Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trials. Cancer Treat Rev. 2012;38:554–8.CrossRefPubMed
11.
go back to reference Aranda S, Schofield P, Weih L, Yates P, Milne D, Faulkner R, et al. Mapping the quality of life and unmet needs of urban women with metastatic breast cancer. Eur J Cancer Care. 2005;14:211–22.CrossRef Aranda S, Schofield P, Weih L, Yates P, Milne D, Faulkner R, et al. Mapping the quality of life and unmet needs of urban women with metastatic breast cancer. Eur J Cancer Care. 2005;14:211–22.CrossRef
12.
go back to reference Kim EJ, Ko SK, Kang HY. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients. Qual Life Res. 2012;21:1193–203.CrossRefPubMed Kim EJ, Ko SK, Kang HY. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients. Qual Life Res. 2012;21:1193–203.CrossRefPubMed
14.
go back to reference Hamalainen HP, Suni JH, Pasanen ME, Malmberg JJ, Miilunpalo SI. Predictive value of health-related fitness tests for self-reported mobility difficulties among high-functioning elderly men and women. Aging Clin Exp Res. 2006;18:218–26.CrossRefPubMed Hamalainen HP, Suni JH, Pasanen ME, Malmberg JJ, Miilunpalo SI. Predictive value of health-related fitness tests for self-reported mobility difficulties among high-functioning elderly men and women. Aging Clin Exp Res. 2006;18:218–26.CrossRefPubMed
15.
go back to reference Bohannon RW, Larkin PA, Cook AC, Gear J, Singer J. Decrease in timed balance test scores with aging. Phys Ther. 1984;64:1067–70.PubMed Bohannon RW, Larkin PA, Cook AC, Gear J, Singer J. Decrease in timed balance test scores with aging. Phys Ther. 1984;64:1067–70.PubMed
16.
go back to reference Pohjola L. TOIMIVA tests in estimation on functional capacity of men over 75 years. 2006. Pohjola L. TOIMIVA tests in estimation on functional capacity of men over 75 years. 2006.
17.
go back to reference Suni JH, Oja P, Laukkanen RT, Miilunpalo SI, Pasanen ME, Vuori IM, et al. Health-related fitness test battery for adults: aspects of reliability. Arch Phys Med Rehabil. 1996;77:399–405.CrossRefPubMed Suni JH, Oja P, Laukkanen RT, Miilunpalo SI, Pasanen ME, Vuori IM, et al. Health-related fitness test battery for adults: aspects of reliability. Arch Phys Med Rehabil. 1996;77:399–405.CrossRefPubMed
18.
go back to reference Bohannon RW. Comfortable and maximum walking speed of adults aged 20–79 years: reference values and determinants. Age Ageing. 1997;26:15–9.CrossRefPubMed Bohannon RW. Comfortable and maximum walking speed of adults aged 20–79 years: reference values and determinants. Age Ageing. 1997;26:15–9.CrossRefPubMed
19.
go back to reference Whittle MW. An introduction to gait analysis. In: David Levine JR, editor. 5th ed. Oxford: Butterworth-Heinemann; 2012. Whittle MW. An introduction to gait analysis. In: David Levine JR, editor. 5th ed. Oxford: Butterworth-Heinemann; 2012.
20.
go back to reference Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Crit Care Med. 1998;158:1384–7.CrossRef Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Crit Care Med. 1998;158:1384–7.CrossRef
21.
go back to reference Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–61.CrossRefPubMed Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–61.CrossRefPubMed
22.
go back to reference Aromaa A, Koskinen S. Terveys ja toimintakyky Suomessa. Terveys 2000-tutkimuksen perustulokset. Terveys 2000. Kansanterveyslaitoksen julkaisuja 2002;B3. Aromaa A, Koskinen S. Terveys ja toimintakyky Suomessa. Terveys 2000-tutkimuksen perustulokset. Terveys 2000. Kansanterveyslaitoksen julkaisuja 2002;B3.
23.
go back to reference Alaranta H, Hurri H, Heliovaara M, Soukka A, Harju R. Non-dynamometric trunk performance tests: reliability and normative data. Scand J Rehabil Med. 1994;26:211–5.PubMed Alaranta H, Hurri H, Heliovaara M, Soukka A, Harju R. Non-dynamometric trunk performance tests: reliability and normative data. Scand J Rehabil Med. 1994;26:211–5.PubMed
24.
go back to reference Harkonen R, Piirtomaa M, Alaranta H. Grip strength and hand position of the dynamometer in 204 Finnish adults. J Hand Surg Br. 1993;18:129–32.CrossRefPubMed Harkonen R, Piirtomaa M, Alaranta H. Grip strength and hand position of the dynamometer in 204 Finnish adults. J Hand Surg Br. 1993;18:129–32.CrossRefPubMed
25.
go back to reference Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ. 1993;2:217–27.CrossRefPubMed Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ. 1993;2:217–27.CrossRefPubMed
26.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed
27.
go back to reference Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–45.CrossRefPubMed Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–45.CrossRefPubMed
28.
go back to reference Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep. 1974;34:1184–6.PubMed Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep. 1974;34:1184–6.PubMed
29.
go back to reference Kautio AL, Haanpaa M, Kautiainen H, Kalso E, Saarto T. Burden of chemotherapy-induced neuropathy—a cross-sectional study. Support Care Cancer. 2011;19:1991–6.CrossRefPubMed Kautio AL, Haanpaa M, Kautiainen H, Kalso E, Saarto T. Burden of chemotherapy-induced neuropathy—a cross-sectional study. Support Care Cancer. 2011;19:1991–6.CrossRefPubMed
30.
go back to reference Sylliaas H, Thingstad P, Wyller TB, Helbostad J, Sletvold O, Bergland A. Prognostic factors for self-rated function and perceived health in patient living at home three months after a hip fracture. Disabil Rehabil. 2012;34:1225–31.CrossRefPubMed Sylliaas H, Thingstad P, Wyller TB, Helbostad J, Sletvold O, Bergland A. Prognostic factors for self-rated function and perceived health in patient living at home three months after a hip fracture. Disabil Rehabil. 2012;34:1225–31.CrossRefPubMed
31.
go back to reference Sallinen J, Stenholm S, Rantanen T, Heliovaara M, Sainio P, Koskinen S. Hand-grip strength cut points to screen older persons at risk for mobility limitation. J Am Geriatr Soc. 2010;58:1721–6.CrossRefPubMedPubMedCentral Sallinen J, Stenholm S, Rantanen T, Heliovaara M, Sainio P, Koskinen S. Hand-grip strength cut points to screen older persons at risk for mobility limitation. J Am Geriatr Soc. 2010;58:1721–6.CrossRefPubMedPubMedCentral
32.
go back to reference Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289:2387–92.CrossRefPubMed Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289:2387–92.CrossRefPubMed
33.
go back to reference Cheville AL, Basford JR, Troxel AB, Kornblith AB. Performance of common clinician- and self-report measures in assessing the function of community-dwelling people with metastatic breast cancer. Arch Phys Med Rehabil. 2009;90:2116–24.CrossRefPubMed Cheville AL, Basford JR, Troxel AB, Kornblith AB. Performance of common clinician- and self-report measures in assessing the function of community-dwelling people with metastatic breast cancer. Arch Phys Med Rehabil. 2009;90:2116–24.CrossRefPubMed
34.
go back to reference Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34:94–104.CrossRefPubMed Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34:94–104.CrossRefPubMed
35.
go back to reference Penttinen HM, Saarto T, Kellokumpu-Lehtinen P, Blomqvist C, Huovinen R, Kautiainen H, et al. Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments. Psychooncology. 2011;20:1211–20.CrossRefPubMed Penttinen HM, Saarto T, Kellokumpu-Lehtinen P, Blomqvist C, Huovinen R, Kautiainen H, et al. Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments. Psychooncology. 2011;20:1211–20.CrossRefPubMed
36.
go back to reference Pirkola SP, Isometsa E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population–results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol. 2005;40:1–10.CrossRefPubMed Pirkola SP, Isometsa E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population–results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol. 2005;40:1–10.CrossRefPubMed
37.
go back to reference Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage. 2008;35:644–55.CrossRefPubMed Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage. 2008;35:644–55.CrossRefPubMed
38.
go back to reference Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30:112–26.CrossRefPubMed Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30:112–26.CrossRefPubMed
39.
go back to reference van Milligen BA, Lamers F, de Hoop GT, Smit JH, Penninx BW. Objective physical functioning in patients with depressive and/or anxiety disorders. J Affect Disord. 2011;131:193–9.CrossRefPubMed van Milligen BA, Lamers F, de Hoop GT, Smit JH, Penninx BW. Objective physical functioning in patients with depressive and/or anxiety disorders. J Affect Disord. 2011;131:193–9.CrossRefPubMed
40.
go back to reference Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30–reference values from a large sample of Swedish population. Acta Oncol. 2000;39:477–84.CrossRefPubMed Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30–reference values from a large sample of Swedish population. Acta Oncol. 2000;39:477–84.CrossRefPubMed
Metadata
Title
The functional capacity and quality of life of women with advanced breast cancer
Authors
K. Kokkonen
T. Saarto
T. Mäkinen
L. Pohjola
H. Kautio
S. Järvenpää
K. Puustjärvi-Sunabacka
Publication date
01-01-2017
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2017
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-016-0687-2

Other articles of this Issue 1/2017

Breast Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine